awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q42720284-4B85AB4F-34F2-4B39-89D9-A3B001C381CF
Q42720284-4B85AB4F-34F2-4B39-89D9-A3B001C381CF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42720284-4B85AB4F-34F2-4B39-89D9-A3B001C381CF
Phase 2 study of the JAK kinase inhibitor ruxolitinib in patients with refractory leukemias, including postmyeloproliferative neoplasm acute myeloid leukemia.
P2860
Q42720284-4B85AB4F-34F2-4B39-89D9-A3B001C381CF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42720284-4B85AB4F-34F2-4B39-89D9-A3B001C381CF
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
91d5d0662673cd0b24f2a9b4cafa359dcc7fa9a4
P2860
Therapeutic options for patients with myelofibrosis in blast phase.